97 related articles for article (PubMed ID: 15679784)
21. Are heterogenous results of EGFR immunoreactivity in renal cell carcinoma related to non-standardised criteria for staining evaluation?
Langner C; Ratschek M; Rehak P; Schips L; Zigeuner R
J Clin Pathol; 2004 Jul; 57(7):773-5. PubMed ID: 15220376
[TBL] [Abstract][Full Text] [Related]
22. Hypoxia-inducible factor 1 alpha in clear cell renal cell carcinoma.
Klatte T; Seligson DB; Riggs SB; Leppert JT; Berkman MK; Kleid MD; Yu H; Kabbinavar FF; Pantuck AJ; Belldegrun AS
Clin Cancer Res; 2007 Dec; 13(24):7388-93. PubMed ID: 18094421
[TBL] [Abstract][Full Text] [Related]
23. Small renal tumors: correlation of clinical and pathological features with tumor size.
Pahernik S; Ziegler S; Roos F; Melchior SW; Thüroff JW
J Urol; 2007 Aug; 178(2):414-7; discussion 416-7. PubMed ID: 17561161
[TBL] [Abstract][Full Text] [Related]
24. [Prognostic value of morphologic subdivision of papillary renal cell carcinoma and MUC1 expression].
Blel A; Kourda N; Baltagi Ben Jilani S; Zermani R
Prog Urol; 2008 Oct; 18(9):575-9. PubMed ID: 18986629
[TBL] [Abstract][Full Text] [Related]
25. Caspase-8 and its inhibitors in RCCs in vivo: the prominent role of ARC.
Heikaus S; Kempf T; Mahotka C; Gabbert HE; Ramp U
Apoptosis; 2008 Jul; 13(7):938-49. PubMed ID: 18516683
[TBL] [Abstract][Full Text] [Related]
26. Expression analysis of kidney-specific cadherin in a wide spectrum of traditional and newly recognized renal epithelial neoplasms: diagnostic and histogenetic implications.
Kuehn A; Paner GP; Skinnider BF; Cohen C; Datta MW; Young AN; Srigley JR; Amin MB
Am J Surg Pathol; 2007 Oct; 31(10):1528-33. PubMed ID: 17895753
[TBL] [Abstract][Full Text] [Related]
27. Expression of IGF-I, IGF-II, and IGF-IR in gallbladder carcinoma. A systematic analysis including primary and corresponding metastatic tumours.
Kornprat P; Rehak P; Rüschoff J; Langner C
J Clin Pathol; 2006 Feb; 59(2):202-6. PubMed ID: 16443739
[TBL] [Abstract][Full Text] [Related]
28. Differential expression of prognostic markers in histological subtypes of papillary renal cell carcinoma.
Perret AG; Clemencon A; Li G; Tostain J; Peoc'h M
BJU Int; 2008 Jul; 102(2):183-7. PubMed ID: 18422770
[TBL] [Abstract][Full Text] [Related]
29. Bilateral synchronous sporadic renal cell carcinoma: surgical management, oncological and functional outcomes.
Pahernik S; Cudovic D; Roos F; Melchior SW; Thüroff JW
BJU Int; 2007 Jul; 100(1):26-9. PubMed ID: 17552949
[TBL] [Abstract][Full Text] [Related]
30. Over expression of insulin-like growth factor binding protein 3 in clear cell renal cell carcinoma.
Chuang ST; Patton KT; Schafernak KT; Papavero V; Lin F; Baxter RC; Teh BT; Yang XJ
J Urol; 2008 Feb; 179(2):445-9. PubMed ID: 18076934
[TBL] [Abstract][Full Text] [Related]
31. Does renal capsular invasion have any prognostic value in localized renal cell carcinoma?
Süer E; Ergün G; Baltaci S; Bedük Y
J Urol; 2008 Jul; 180(1):68-71. PubMed ID: 18485385
[TBL] [Abstract][Full Text] [Related]
32. The role of epidermal growth factor receptor and E-cadherin for the outcome of reduction in the overall treatment time of radiotherapy of supraglottic larynx squamous cell carcinoma.
Eriksen JG; Steiniche T; Overgaard J;
Acta Oncol; 2005; 44(1):50-8. PubMed ID: 15848906
[TBL] [Abstract][Full Text] [Related]
33. Hybrid tumour 'oncocytoma-chromophobe renal cell carcinoma' of the kidney: a report of seven sporadic cases.
Delongchamps NB; Galmiche L; Eiss D; Rouach Y; Vogt B; Timsit MO; Vieillefond A; Méjean A
BJU Int; 2009 May; 103(10):1381-4. PubMed ID: 19154497
[TBL] [Abstract][Full Text] [Related]
34. Significance of Fas expression alteration during tumor progression of renal cell carcinoma.
Sejima T; Miyagawa I
Int J Urol; 2006 Mar; 13(3):257-64. PubMed ID: 16643620
[TBL] [Abstract][Full Text] [Related]
35. Tissue expression and plasma levels of adrenomedullin in renal cancer patients.
Michelsen J; Thiesson H; Walter S; Ottosen PD; Skøtt O; Jensen BL
Clin Sci (Lond); 2006 Jul; 111(1):61-70. PubMed ID: 16515534
[TBL] [Abstract][Full Text] [Related]
36. [Four cases of sarcomatoid renal cell carcinoma].
Takada T; Kinouchi T; Kinoshita T; Hatano K; Kobayashi M; Inoue H; Hara T; Yamaguchi S
Hinyokika Kiyo; 2009 Feb; 55(2):93-7. PubMed ID: 19301614
[TBL] [Abstract][Full Text] [Related]
37. Differential expression of caveolin-1 in renal neoplasms.
Tamaskar I; Choueiri TK; Sercia L; Rini B; Bukowski R; Zhou M
Cancer; 2007 Aug; 110(4):776-82. PubMed ID: 17594718
[TBL] [Abstract][Full Text] [Related]
38. Impact of tumor size on the predictive ability of the pT3a primary tumor classification for renal cell carcinoma.
Siddiqui SA; Frank I; Leibovich BC; Cheville JC; Lohse CM; Zincke H; Blute ML
J Urol; 2007 Jan; 177(1):59-62. PubMed ID: 17162000
[TBL] [Abstract][Full Text] [Related]
39. Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma.
Lam JS; Shvarts O; Said JW; Pantuck AJ; Seligson DB; Aldridge ME; Bui MH; Liu X; Horvath S; Figlin RA; Belldegrun AS
Cancer; 2005 Jun; 103(12):2517-25. PubMed ID: 15880379
[TBL] [Abstract][Full Text] [Related]
40. Independent validation of the 2002 American Joint Committee on cancer primary tumor classification for renal cell carcinoma using a large, single institution cohort.
Frank I; Blute ML; Leibovich BC; Cheville JC; Lohse CM; Zincke H
J Urol; 2005 Jun; 173(6):1889-92. PubMed ID: 15879769
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
